BRIEF-Intelgenx Technologies to start phase 1 trial of Montelukast

Wed Jul 13, 2016 8:54am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 13 (Reuters) - Intelgenx Technologies Corp

* Intelgenx to initiate phase 1 trial of Montelukast

* Intelgenx expects results from phase 1 trial to be available in September 2016

* Will be seeking partnership or alliance opportunity to complete remaining developmental work, commercialization of product Source text for Eikon: Further company coverage: